Source: Empower Clinics.
  • Empower’s (EPW) Medisure Labs subsidiary signed a laboratory services agreement with Specialist Network of North America (SNNA)
  • SNNA will now be able to offer a full range of cardiology screening panels and point-of-care testing products
  • The agreement follows their partnership to launch a healthcare network to bring affordable specialist healthcare to underserved Americans
  • Empower is an integrated healthcare company providing body and mind wellness
  • Empower Clinics (EPW) is down by 16.67 per cent, trading at $0.025 per share

Empower’s (EPW) Medisure Labs subsidiary signed a laboratory services agreement with SNNA.

SNNA is a healthcare network catering to underserved communities across the U.S. It operates through a collaborative network of strategic partnerships, including clinics, telemedicine and insurance providers.

Medisure is a high-complexity lab providing diagnostic services and testing solutions.

The agreement will allow SNNA to offer a full range of cardiology screening panels and point-of-care testing products.

The agreement follows Empower and SNNA’s partnership, announced on December 7th, to launch a healthcare network to bring affordable specialist healthcare to underserved Americans.

“This agreement is exactly the type of accretive benefit that I envisioned when Empower partnered with SNNA last month,” stated Steven McAuley, Empower’s Chairman and CEO. “With Medisure Labs, we have a laboratory that has state-of-the-art technology and a pristine operating environment. We continue to aggressively pursue and replicate laboratory service agreements like the one with SNNA to maximize our return on investment in Medisure.”

Empower is an integrated healthcare company providing body and mind wellness through clinics, digital and telemedicine care, medical devices and medical diagnostic laboratories.

Empower Clinics (EPW) is down by 16.67 per cent, trading at $0.025 per share as of 12:45 pm ET.


More From The Market Online
stock market down

@ the Bell: Industrials weakness snaps TSX win streak

Industrials led decliners, followed by financials, to snap the TSX’s five-day win streak while energy, utilities and mining provided gains.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.